Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...
John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...
The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...
A large meta-analysis sheds light on the best antipsychotic maintenance strategy to prevent relapse in clinically-stable schizophrenia — with some unexpected results that have potential implications ...
For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...
Please provide your email address to receive an email when new articles are posted on . Abatacept treatment after ustekinumab withdrawal did not prevent psoriasis relapse, according to a randomized ...
Relapses in a common form of leukemia may be preventable following new research which has identified how the cancer develops resistance to first line treatments. New research published in iScience by ...
New findings suggest that treating insomnia can stop opioid-seeking behavior, even after ending treatment. A good night's sleep has many proven health benefits, and a new Scripps Research study ...
Gradual reduction of antidepressants together with psychological support can be an effective strategy to stop medication among adults who have recovered from depression, according to a study on Friday ...
Major depressive disorder or what is more commonly known as clinical depression is a significant condition that can impact many aspects of people’s lives. It causes prolonged and persistent symptoms ...
Using e-cigarettes and other tobacco products to keep from relapsing to cigarettes doesn't appear to be effective, according to a new longitudinal study of nearly 13,000 smokers in the United States.